FDA 483 - Apotex Research Private Limited

An FDA inspection of Apotex Research Private Limited in Bangalore, India, revealed significant deficiencies in manufacturing process validation, laboratory controls, and quality unit procedures. The firm failed to thoroughly investigate discrepancies, maintain equipment, and ensure proper documentation and tracking of materials and samples. Repeat observations were noted regarding control procedures and the stability testing program, indicating systemic issues.